Pamela Stahl appointed chief commercial officer of InVivo Therapeutics

InVivo Therapeutics' flagship Neuro-spinal scaffold
InVivo Therapeutics’ flagship Neuro-spinal scaffold

InVivo Therapeutics Holdings has appointed Pamela Stahl to the newly-created position of chief commercial officer, effective September 14, 2016.

Prior to joining InVivo, Stahl served for 10 years in various roles of at UnitedHealthcare, most recently as chief executive officer, Community Health Plan of Wisconsin. In that role, she was responsible for the largest Medicaid business in the state, providing healthcare benefits and services for over 160,000 Wisconsin residents. Stahl also held other senior vice president roles at UnitedHealthcare with responsibilities for the Office of the Consumer; Sales Operations and Organizational Effectiveness; the Women’s Health Line of Service; and Consumer Marketing.

Prior to UnitedHealthcare, Stahl was vice president, Sales and Commercial Operations for Orphan Medical, from 2001 to 2006. She built and supervised a specialty sales force and established the sales operation function, implemented a risk management program, and created the patient affairs department. Before that, she served as vice president, Sales and Marketing for American TeleCare. From 1992 until 2000 she held various sales and marketing roles of increasing responsibility at AstraZeneca, including regional marketing manager, account team leader, customer unit director, product optimization Leader, and regional sales director. Stahl began her sales career at Merck & Co.

Stahl has been a contributing member of many US organisations including the National Organization for Rare Diseases Corporate Council, National Association of Drug Diversion Investigators, National Association of State Controlled Substances Authorities, National Stakeholder Workgroup for Childbirth Connection, and the UnitedHealthcare Women’s Health Scientific Advisory Board (Chair). She holds a Bachelor of Arts in Biology from St. Olaf College, Northfield, USA.